Tryn Stimart - Net Worth and Insider Trading
Tryn Stimart Net Worth
The estimated net worth of Tryn Stimart is at least $1,920 dollars as of 2024-04-29. Tryn Stimart is the Chief Legal Officer of AbCellera Biologics Inc and owns about 500 shares of AbCellera Biologics Inc (ABCL) stock worth over $1,920. Details can be seen in Tryn Stimart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tryn Stimart has not made any transactions after 2021-06-09 and currently still holds the listed stock(s).
Transaction Summary of Tryn Stimart
Tryn Stimart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tryn Stimart owns 1 companies in total, including AbCellera Biologics Inc (ABCL) .
Click here to see the complete history of Tryn Stimart’s form 4 insider trades.
Insider Ownership Summary of Tryn Stimart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABCL | AbCellera Biologics Inc | 2021-06-09 | Chief Legal Officer |
Tryn Stimart Latest Holdings Summary
Tryn Stimart currently owns a total of 1 stock. Tryn Stimart owns 500 shares of AbCellera Biologics Inc (ABCL) as of June 9, 2021, with a value of $1,920.
Latest Holdings of Tryn Stimart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc | 2021-06-09 | 500 | 3.84 | 1,920 |
Holding Weightings of Tryn Stimart
Tryn Stimart Form 4 Trading Tracker
According to the SEC Form 4 filings, Tryn Stimart has made a total of 2 transactions in AbCellera Biologics Inc (ABCL) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in AbCellera Biologics Inc is the sale of 1,000,000 shares on June 9, 2021, which brought Tryn Stimart around $26 Million.
Insider Trading History of Tryn Stimart
- 1
Tryn Stimart Trading Performance
GuruFocus tracks the stock performance after each of Tryn Stimart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tryn Stimart is -20.09%. GuruFocus also compares Tryn Stimart's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tryn Stimart within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tryn Stimart's insider trading performs compared to the benchmark.
Performance of Tryn Stimart
Average Return
-72.36%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.49 | -20.09 | -49.93 | -72.36 | -52.95 | -51.29 |
| Relative Return to S&P 500(%) | -7.48 | -27.51 | -64.87 | -99.84 | -55.64 | -59.79 |
Tryn Stimart Ownership Network
Ownership Network List of Tryn Stimart
Ownership Network Relation of Tryn Stimart
Tryn Stimart Owned Company Details
What does AbCellera Biologics Inc do?
Who are the key executives at AbCellera Biologics Inc?
Tryn Stimart is the Chief Legal Officer of AbCellera Biologics Inc. Other key executives at AbCellera Biologics Inc include director & Chief Operating Officer Veronique Lecault , Chief Financial Officer Andrew Booth , and 10 percent owner Thermopylae Holdings Ltd. .
AbCellera Biologics Inc (ABCL) Insider Trades Summary
Over the past 18 months, Tryn Stimart made no insider transaction in AbCellera Biologics Inc (ABCL). Other recent insider transactions involving AbCellera Biologics Inc (ABCL) include a net purchase of 238,102 shares made by Thermopylae Holdings Ltd. , a net purchase of 50,000 shares made by Michael R Hayden , and a net purchase of 30,000 shares made by John S. Montalbano .
In summary, during the past 3 months, insiders sold 0 shares of AbCellera Biologics Inc (ABCL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AbCellera Biologics Inc (ABCL) were sold and 352,602 shares were bought by its insiders, resulting in a net purchase of 352,602 shares.
AbCellera Biologics Inc (ABCL)'s detailed insider trading history can be found in Insider Trading Tracker table.
AbCellera Biologics Inc Insider Transactions
Tryn Stimart Mailing Address
Above is the net worth, insider trading, and ownership report for Tryn Stimart. You might contact Tryn Stimart via mailing address: C/o Abcellera Biologics Inc., 2215 Yukon Street, Vancouver A1 V5y 0a1.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
